- Tytuł:
- Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology October 2021 22(10):1378-1390
Czasopismo naukowe